Condition: Asthma
Interventions: Biological: Mepolizumab; Drug: Placebo; Drug: SOC
Sponsor: GlaxoSmithKline
Not yet recruiting – verified October 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Efficacy and Safety of LAIS® Mites Sublingual Tablets
Condition: Allergic Conditions
Intervention: Drug: LAIS®
Sponsor: Ajou University School of Medicine
Not yet recruiting – verified October 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
A Non-inferiority Study to Evaluate Efficacy, Safety and Tolerability of NEUMOTEROL® 400 and SYMBICORT® Forte in Adults With Asthma
Condition: Asthma
Interventions: Drug: NEUMOTEROL 400 (BFF 400/12 mcg) single capsule inhaler; Drug: SYMBICORT forte (BFF 320/9mcg) TURBUHALER inhaler; Drug: NEUMOTEX 400 (Budesonide 400 mcg); Drug: Salbutamol 100 mcg pMDI
Sponsors: GlaxoSmithKline; Laboratorios Phoenix
Not yet recruiting – verified September 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Study to Assess the Efficacy of Ipratropium Bromide Associated With High Dose Salbutamol by Repeated Nebulisation Versus Repeat Nebulisation of Salbutamol Alone, in Acute Asthmatic Attacks in Young Children
Condition: Asthma
Interventions: Drug: Ipratropium bromide; Drug: Placebo; Drug: Salbutamol
Sponsor: Boehringer Ingelheim
Terminated – verified September 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma (D2210C00008)
Condition: Uncontrolled Asthma
Interventions: Biological: Tralokinumab; Biological: Placebo
Sponsor: AstraZeneca
Not yet recruiting – verified July 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Safety and Efficacy of Berodual® Inhaled Via Respimat® Compared to MDI (Metered Dose Inhaler) in Pediatric Patients With Asthma
Condition: Asthma
Interventions: Drug: Berodual® Respimat®, low dose; Drug: Berodual® Respimat®, high dose; Drug: Berodual® MDI
Sponsor: Boehringer Ingelheim
Completed – verified July 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Efficacy and Safety of Combivent® Aerosol and Spacer, in Adult Patients With Moderate to Severe Asthma Crisis
Condition: Asthma
Intervention: Drug: salbutamol sulfate + ipratropium bromide
Sponsor: Boehringer Ingelheim
Terminated – verified July 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Efficacy and Safety Study Comparing Respimat ® Budesonide With Turbohaler ® Budesonide in Symptomatic Adult Moderate to Severe Asthmatics Requiring Inhaled Corticosteroids and Bronchodilator Therapy
Condition: Asthma
Interventions: Drug: Respimat® Budesonide low dose; Drug: Respimat® Budesonide high dose; Drug: Turbohaler® Budesonide; Drug: Placebo
Sponsor: Boehringer Ingelheim
Completed – verified July 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Efficacy Study of Synbitide HFA MDI in Asthma Patients
Condition: Asthma
Interventions: Drug: Budesonide/Procaterol, 180/10mcg X1; Drug: Budesonide/procaterol 180/10 mcg X 2; Drug: Albuterol HFA MDI 100mcg X2
Sponsor: Intech Biopharm Ltd.
Recruiting – verified June 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Efficacy of Inhalation Technique Training.
Conditions: Asthma; Chronic Obstructive Pulmonary Disease
Intervention: Other: Inhalation technique training
Sponsor: Medical University of Warsaw
Recruiting – verified May 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days